Archives
-
AEBSF.HCl: Serine Protease Inhibition Guide
2026-09-20
AEBSF.HCl, also called 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride, is an irreversible broad-spectrum serine protease inhibitor for mechanistic research. Product-reported benchmarks cover amyloid precursor protein cleavage, amyloid-beta production, leukemic cell lysis, implantation, solubility, and storage, while peer-reviewed evidence places lysosomal cathepsin activity within necroptosis biology.
-
Leupeptin in Protease-Controlled TET2 Workflows
2026-09-19
Leupeptin combines reversible, competitive inhibition of serine and cysteine proteases with practical utility in lysate protection, autophagy, and antiviral experiments. This guide shows how to use Leupeptin hemisulfate salt without compromising TET2 activity assays, metabolite-binding measurements, or interpretation of protein degradation data.
-
Caspase-3/7 Inhibitor I: Applied Assay Guide
2026-09-18
Caspase-3/7 Inhibitor I provides a reversible, cell-permeable checkpoint for separating executioner-caspase activity from upstream stress, receptor, and mitochondrial signals. This guide translates Candida krusei–induced apoptosis findings into practical co-culture, washout, endpoint, and troubleshooting workflows.
-
T0070907: A Causal Map of PPARγ Signaling
2026-09-18
T0070907 is a covalent PPARγ antagonist for dissecting receptor-dependent transcription, adipogenesis inhibition, and cell-cycle phenotypes. This article connects its assay behavior to RXRα/PPARγ/NEDD4 research and provides a decision framework for separating direct pathway effects from secondary cellular responses.
-
SMPD4, Ceramide, and Primary Cilia in Brain Development
2026-09-17
The 2024 Development study identifies SMPD4-dependent ceramide production as a mechanistic link between sphingolipid metabolism, primary cilium integrity, neural progenitor survival, and brain development. By combining a mouse model with SMPD4-deficient human iPSCs, the authors show that impaired ceramide production contributes to cerebellar hypoplasia and shortened primary cilia, with ciliary defects rescued by exogenous ceramide.
-
Curcumol, KAT8, and HK2 Lactylation in Fibrosis
2026-09-17
The reference study identifies a lactate–KAT8–HK2 regulatory circuit that sustains activated hepatic stellate cells and shows that Curcumol can disrupt this circuit to promote RIPK1/RIPK3/MLKL-dependent necroptosis. Its combined cellular and CCl4-induced fibrosis models connect metabolic reprogramming, post-translational modification, and HSC elimination, while KAT8 overexpression provides mechanistic validation.
-
Lambda Protein Phosphatase for BMAL1 Assays
2026-09-16
Use Lambda Protein Phosphatase to distinguish phosphorylation-dependent BMAL1 behavior from changes caused by protein abundance, antibody bias, or sample handling. This workflow connects phospho-specific antibody validation with condensate imaging, transcriptional readouts, and rigorous phosphorylation site validation.
-
Novobiocin Links DNA Replication to Protoplast Growth
2026-09-16
Tsuchikado and colleagues show that DNA replication is functionally connected to plasma membrane synthesis and vacuole formation during enlargement of Enterococcus faecalis protoplasts. By varying the timing of novobiocin exposure, the study identifies a reversible, replication-dependent control point in bacterial morphogenesis and provides a framework for separating replication arrest from DNA degradation.
-
Z-VDVAD-FMK in Apoptosis Assays
2026-09-15
Z-VDVAD-FMK helps separate caspase-2-associated mitochondrial apoptosis from caspase-1-driven pyroptosis, making it valuable for mechanistic apoptosis assays and cancer research. This workflow combines controlled inhibitor exposure, orthogonal death readouts, and troubleshooting strategies to distinguish pathway suppression from caspase-independent cell death.
-
MAPK10–KRT16 Signaling in NSCLC Metastasis
2026-09-15
The reference study identifies MAPK10 as a suppressor of non-small cell lung cancer metastasis by phosphorylating KRT16 at Ser356 and Ser397, enabling RNF213-mediated ubiquitination and proteasomal degradation. Its combination of mechanistic, functional, animal, and clinical analyses supports the MAPK10/KRT16/RNF213 axis as a prognostic framework, while also highlighting important limits for therapeutic interpretation.
-
Lambda Protein Phosphatase for BMAL1 Studies
2026-09-14
Use Lambda Protein Phosphatase to test whether BMAL1 phosphorylation changes condensate formation, antibody recognition, or transcriptional activity. This workflow combines controlled dephosphorylation, phospho-specific antibody validation, and phase-separation assays with practical controls for Mn2+, inhibitors, and sample handling.
-
Structure-Guided Proteomimetics Target SARS-CoV-2 Entry
2026-09-14
The reference study uses structure-guided alanine mutagenesis, peptide stapling, and macrocyclization to reproduce key hACE2 recognition elements at the SARS-CoV-2 Spike receptor-binding interface. Its lead proteomimetic, compound 28, disrupted S-RBD/hACE2 binding and pseudovirus entry while showing epithelial stability and low permeability that support further investigation of localized antiviral delivery.
-
Thrombin B Chain: A Translational Control Point
2026-09-13
Thrombin is more than a coagulation trigger: it links fibrin formation, platelet signaling, vascular remodeling, and disease biology. This thought-leadership analysis shows how the defined Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] can support better-controlled translational workflows while clarifying the limits of extrapolating from a peptide fragment to full-length enzyme activity.
-
Valemetostat and Dual EZH1/2 Inhibition in ATL
2026-09-12
The reference paper examines valemetostat, the first approved dual EZH1/2 inhibitor for relapsed or refractory adult T-cell leukemia/lymphoma, and explains why simultaneous blockade may overcome compensation by EZH1 and EZH2. Its clinical evidence and epigenetic rationale support dual-target inhibition as a meaningful strategy while also highlighting the need for larger, controlled studies.
-
Grx2, HNRNPA2B1, and Diabetic Cataract Ferroptosis
2026-09-11
The 2025 reference study identifies a redox-regulatory mechanism in which glutaredoxin 2 protects lens epithelial cells from high-glucose-induced ferroptosis by limiting HNRNPA2B1 S-glutathionylation. Its integrated proteomic, biochemical, and cell-based approach connects this modification to PTEN/AKT signaling, mitochondrial dysfunction, and diabetes-mediated cataractogenesis.